REFERENCES
1. Felicetti M, Cazzador D, Padoan R, et al. Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes. Clin Rheumatol 2018;37:1075-83.
2. Hernández-Rodríguez J, Hoffman GS, Koening CL. Surgical interventions and local therapy for Wegener's granulomatosis. Curr Opin Rheumatol 2010;22:29-36.
3. Hauer HA, Bajema IM, van Houwelingen HC, et al. European Vasculitis Study Group (EUVAS). Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002;61:80-9.
4. JH; Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003;48:2299-309.
5. Srouji IA, Andrews P, Edwards C, Lund VJ. Patterns of presentation and diagnosis of patients with Wegener's granulomatosis: ENT aspects. J Laryngol Otol 2007;121:653-8.
6. Cannady SB, Batra PS, Koening C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 2009;119:757-61.
7. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
8. Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener's granulomatosis. Rheum Dis Clin North Am 2010;36:507-26.
9. Alaani A, Hogg RP, Drake Lee AB. Wegener's granulomatosis and subglottic stenosis: management of the airway. J Laryngol Otol 2004;118:786-90.
10. Polychronopoulos VS, Prakash UB, Golbin JM, Edell ES, Specks U. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 2007;33:755-75, vi.
11. Stappaerts I, Van Laer C, Deschepper K, Van de Heyning P, Vermeire P. Endoscopic management of severe subglottic stenosis in Wegener's granulomatosis. Clin Rheumatol 2000;19:315-7.
12. Nouraei SA, Obholzer R, Ind PW, et al. Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis. Thorax 2008;63:49-52.
13. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001;13:3-11.
14. McCaffrey TV, McDonald TJ, Facer GW, DeRemee RA. . Otologic manifestations of Wegener’s granulomatosis. Otolaryngol Head Neck Surg (1979) 1980;88:586-93.
15. Santos F, Salviz M, Domond H, Nadol JB. Otopathology of vasculitis in granulomatosis with polyangitis. Otol Neurotol 2015;36:1657-62.
17. Langford CA, Sneller MC, Hallahan CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 1996;39:1754-60.
18. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis & Rheumatism 1998;41:1521-37.
19. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
20. Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol 2005;19:263-76.
21. Nakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol 2019;15:91-101.
22. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
23. D'Anza B, Langford CA, Sindwani R. Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): a systematic review. Am J Rhinol Allergy 2017;31:16-21.
25. Solans-Laqué R, Bosch-Gil J, Canela M, Lorente J, Pallisa E, Vilardell-Tarrés M. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Lupus 2008;17:832-6.
26. Girard C, Charles P, Terrier B, et al. Tracheobronchial stenoses in granulomatosis with polyangiitis (Wegener's): a report on 26 cases. Medicine (Baltimore) 2015;94:e1088.
27. Agrawal A, Sahni S, Marder G, Shah R, Talwar A. Biphasic flow-volume loop in granulomatosis with polyangiitis related unilateral bronchus obstruction. Respir Investig 2016;54:280-3.
28. Maguchi S, Fukuda S, Takizawa M. Histological findings in biopsies from patients with cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis. Auris Nasus Larynx 2001;28:S53-8.
29. Devaney KO, Travis WD, Hoffman G, Leavitt R, Lebovics R, Fauci AS. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990;14:555-64.
30. Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016;75:1583-94.
31. Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR Standards. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 2014;53:2306-9.
32. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20.
33. Ezzat WH, Compton RA, Basa KC, Levi J. Reconstructive techniques for the saddle nose deformity in granulomatosis with polyangiitis: a systematic review. JAMA Otolaryngol Head Neck Surg 2017;143:507-12.
34. Coordes A, Loose SM, Hofmann VM, et al. Saddle nose deformity and septal perforation in granulomatosis with polyangiitis. Clin Otolaryngol 2018;43:291-9.
